Macia, E.; Vazquez-Rojas, M.; Robiolo, A.; Fayad, R.; Abélanet, S.; Mus-Veteau, I.; Fontaine-Vive, F.; Mehiri, M.; Luton, F.; Franco, M.
Chlortetracycline, a Novel Arf Inhibitor That Decreases the Arf6-Dependent Invasive Properties of Breast Cancer Cells. Molecules 2021, 26, 969.
https://doi.org/10.3390/molecules26040969
AMA Style
Macia E, Vazquez-Rojas M, Robiolo A, Fayad R, Abélanet S, Mus-Veteau I, Fontaine-Vive F, Mehiri M, Luton F, Franco M.
Chlortetracycline, a Novel Arf Inhibitor That Decreases the Arf6-Dependent Invasive Properties of Breast Cancer Cells. Molecules. 2021; 26(4):969.
https://doi.org/10.3390/molecules26040969
Chicago/Turabian Style
Macia, Eric, Monserrat Vazquez-Rojas, Alessia Robiolo, Racha Fayad, Sophie Abélanet, Isabelle Mus-Veteau, Fabien Fontaine-Vive, Mohamed Mehiri, Frédéric Luton, and Michel Franco.
2021. "Chlortetracycline, a Novel Arf Inhibitor That Decreases the Arf6-Dependent Invasive Properties of Breast Cancer Cells" Molecules 26, no. 4: 969.
https://doi.org/10.3390/molecules26040969
APA Style
Macia, E., Vazquez-Rojas, M., Robiolo, A., Fayad, R., Abélanet, S., Mus-Veteau, I., Fontaine-Vive, F., Mehiri, M., Luton, F., & Franco, M.
(2021). Chlortetracycline, a Novel Arf Inhibitor That Decreases the Arf6-Dependent Invasive Properties of Breast Cancer Cells. Molecules, 26(4), 969.
https://doi.org/10.3390/molecules26040969